Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272


From patients with arthralgia, pre-RA and recently diagnosed RA: what is the current status of understanding RA pathogenesis?

Molendijk M, Hazes JM, Lubberts E.

RMD Open. 2018 Jan 12;4(1):e000256. doi: 10.1136/rmdopen-2016-000256. eCollection 2018. Review.


Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?

Ten Cate DF, Jacobs JWG, Swen WAA, Hazes JMW, de Jager MH, Basoski NM, Haagsma CJ, Luime JJ, Gerards AH.

Arthritis Res Ther. 2018 Jan 30;20(1):15. doi: 10.1186/s13075-018-1514-2.


Serum Protein N-Glycosylation Changes with Rheumatoid Arthritis Disease Activity during and after Pregnancy.

Reiding KR, Vreeker GCM, Bondt A, Bladergroen MR, Hazes JMW, van der Burgt YEM, Wuhrer M, Dolhain RJEM.

Front Med (Lausanne). 2018 Jan 8;4:241. doi: 10.3389/fmed.2017.00241. eCollection 2017.


Development of a clinical transition pathway for adolescents in the Netherlands.

Walter M, Hazes JM, Dolhain RJ, van Pelt P, van Dijk A, Kamphuis S.

Nurs Child Young People. 2017 Nov 7;29(9):37-43. doi: 10.7748/ncyp.2017.e932.


Absence of ultrasound inflammation in patients presenting with arthralgia rules out the development of arthritis.

van der Ven M, van der Veer-Meerkerk M, Ten Cate DF, Rasappu N, Kok MR, Csakvari D, Hazes JMW, Gerards AH, Luime JJ.

Arthritis Res Ther. 2017 Sep 15;19(1):202. doi: 10.1186/s13075-017-1405-y.


IgA N- and O-glycosylation profiling reveals no association with the pregnancy-related improvement in rheumatoid arthritis.

Bondt A, Nicolardi S, Jansen BC, Kuijper TM, Hazes JMW, van der Burgt YEM, Wuhrer M, Dolhain RJEM.

Arthritis Res Ther. 2017 Jul 5;19(1):160. doi: 10.1186/s13075-017-1367-0.


Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice.

Kuijper TM, Buisman LR, Hazes JM, Weel AE.

J Rheumatol. 2017 Jul;44(7):965-967. doi: 10.3899/jrheum.170334. No abstract available.


High-Frame-Rate Power Doppler Ultrasound Is More Sensitive than Conventional Power Doppler in Detecting Rheumatic Vascularisation.

van der Ven M, Luime JJ, van der Velden LL, Bosch JG, Hazes JMW, Vos HJ.

Ultrasound Med Biol. 2017 Sep;43(9):1868-1879. doi: 10.1016/j.ultrasmedbio.2017.04.027. Epub 2017 Jun 20.


Does prednisone use or disease activity in pregnant women with rheumatoid arthritis influence the body composition of their offspring?

de Steenwinkel FDO, Dolhain RJEM, Hazes JMW, Hokken-Koelega ACS.

Reprod Toxicol. 2017 Aug;71:118-123. doi: 10.1016/j.reprotox.2017.05.002. Epub 2017 May 10.


The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Karreman MC, Luime JJ, Hazes JMW, Weel AEAM.

J Crohns Colitis. 2017 May 1;11(5):631-642. doi: 10.1093/ecco-jcc/jjw199. Review.


Doctors' preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment.

Kuijper TM, Folmer R, Stolk EA, Hazes JMW, Luime JJ.

Arthritis Res Ther. 2017 Apr 26;19(1):78. doi: 10.1186/s13075-017-1287-z.


No clear association between ultrasound remission and health status in rheumatoid arthritis patients in clinical remission.

van der Ven M, Kuijper TM, Gerards AH, Tchetverikov I, Weel AE, van Zeben J, Hazes JM, Luime JJ.

Rheumatology (Oxford). 2017 Aug 1;56(8):1276-1281. doi: 10.1093/rheumatology/kex080.


EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Review.


What support is needed to self-manage a rheumatic disorder: a qualitative study.

Been-Dahmen JM, Walter MJ, Dwarswaard J, Hazes JM, van Staa A, Ista E.

BMC Musculoskelet Disord. 2017 Feb 16;18(1):84. doi: 10.1186/s12891-017-1440-5.


Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?

Pasma A, Schenk C, Timman R, van 't Spijker A, Appels C, van der Laan WH, van den Bemt B, Goekoop R, Hazes JM, Busschbach JJ.

PLoS One. 2017 Feb 2;12(2):e0171070. doi: 10.1371/journal.pone.0171070. eCollection 2017.


Performance of screening tools for psoriatic arthritis: a cross-sectional study in primary care.

Karreman MC, Weel AEAM, van der Ven M, Vis M, Tchetverikov I, Nijsten TEC, Wakkee M, Hazes JMW, Luime JJ.

Rheumatology (Oxford). 2017 Apr 1;56(4):597-602. doi: 10.1093/rheumatology/kew410.


Fab glycosylation of immunoglobulin G does not associate with improvement of rheumatoid arthritis during pregnancy.

Bondt A, Wuhrer M, Kuijper TM, Hazes JM, Dolhain RJ.

Arthritis Res Ther. 2016 Nov 25;18(1):274.


Identifying Clinical Factors Associated With Low Disease Activity and Remission of Rheumatoid Arthritis During Pregnancy.

Ince-Askan H, Hazes JMW, Dolhain RJEM.

Arthritis Care Res (Hoboken). 2017 Sep;69(9):1297-1303. doi: 10.1002/acr.23143. Epub 2017 Aug 13.


Adding ultrasound to clinical examination reduced frequency of enthesitis in primary care psoriasis patients with musculoskeletal complaints.

van der Ven M, Karreman MC, Weel AE, Tchetverikov I, Vis M, Nijsten TE, Hazes JM, Luime JJ.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1020-1025. Epub 2016 Sep 8.


Subfertility in Women With Rheumatoid Arthritis and the Outcome of Fertility Assessments.

Brouwer J, Fleurbaaij R, Hazes JMW, Dolhain RJEM, Laven JSE.

Arthritis Care Res (Hoboken). 2017 Aug;69(8):1142-1149. doi: 10.1002/acr.23124. Epub 2017 Jun 26.


Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial.

de Jong PH, Hazes JM, Buisman LR, Barendregt PJ, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE.

Rheumatology (Oxford). 2016 Dec;55(12):2138-2147. Epub 2016 Aug 30.


Psychosocial predictors of DMARD adherence in the first three months of treatment for early arthritis.

Pasma A, Hazes JM, Busschbach JJ, van der Laan WH, Appels C, de Man YA, Nieboer D, Timman R, van 't Spijker A.

Patient Educ Couns. 2017 Jan;100(1):126-132. doi: 10.1016/j.pec.2016.07.019. Epub 2016 Jul 15.


Focus group interviews reveal reasons for differences in the perception of disease activity in rheumatoid arthritis.

Walter MJ, Van't Spijker A, Pasma A, Hazes JM, Luime JJ.

Qual Life Res. 2017 Feb;26(2):291-298. doi: 10.1007/s11136-016-1369-4. Epub 2016 Jul 21.


Nonadherence to disease modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patients.

Pasma A, den Boer E, van 't Spijker A, Timman R, van den Bemt B, Busschbach JJ, Hazes JM.

Rheumatology (Oxford). 2016 Oct;55(10):1812-9. doi: 10.1093/rheumatology/kew247. Epub 2016 Jun 27.


Longitudinal monitoring of immunoglobulin A glycosylation during pregnancy by simultaneous MALDI-FTICR-MS analysis of N- and O-glycopeptides.

Bondt A, Nicolardi S, Jansen BC, Stavenhagen K, Blank D, Kammeijer GS, Kozak RP, Fernandes DL, Hensbergen PJ, Hazes JM, van der Burgt YE, Dolhain RJ, Wuhrer M.

Sci Rep. 2016 Jun 15;6:27955. doi: 10.1038/srep27955.


A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis.

Buisman LR, Luime JJ, Oppe M, Hazes JM, Rutten-van Mölken MP.

Arthritis Res Ther. 2016 Jun 10;18(1):135. doi: 10.1186/s13075-016-1020-3.


Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.

Kuijper TM, Luime JJ, de Jong PH, Gerards AH, van Zeben D, Tchetverikov I, de Sonnaville PB, van Krugten MV, Grillet BA, Hazes JM, Weel AE.

Ann Rheum Dis. 2016 Dec;75(12):2119-2123. doi: 10.1136/annrheumdis-2016-209272. Epub 2016 Jun 9.


Prevalence of Psoriatic Arthritis in Primary Care Patients With Psoriasis.

Karreman MC, Weel AE, van der Ven M, Vis M, Tchetverikov I, Nijsten TE, Wakkee M, Hazes JM, Luime JJ.

Arthritis Rheumatol. 2016 Apr;68(4):924-31. doi: 10.1002/art.39530.


Is Disease Activity in Rheumatoid Arthritis during Pregnancy and after Delivery Predictive for Disease Activity in a Subsequent Pregnancy?

Ince-Askan H, Hazes JM, Dolhain RJ.

J Rheumatol. 2016 Jan;43(1):22-5. doi: 10.3899/jrheum.150565. Epub 2015 Dec 1.


CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis.

Paulissen SM, van Hamburg JP, Davelaar N, Vroman H, Hazes JM, de Jong PH, Lubberts E.

Arthritis Res Ther. 2015 Nov 30;17:344. doi: 10.1186/s13075-015-0800-5.


Cost-Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis.

Luime JJ, Buisman LR, Oppe M, Hazes JM, Rutten-van Mölken MP.

Arthritis Care Res (Hoboken). 2016 Jul;68(7):927-35. doi: 10.1002/acr.22776.


Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis?

van der Ven M, Alves C, Luime JJ, Gerards AH, Barendregt PJ, van Zeben D, van Schaeybroeck B, de Sonnaville PB, Grillet BA, Hazes JM.

Rheumatology (Oxford). 2016 Apr;55(4):636-9. doi: 10.1093/rheumatology/kev383. Epub 2015 Nov 4.


A Five-Year Model to Assess The Cost-Effectiveness of New Diagnostic Tests In The Early Diagnosis of Rheumatoid Arthritis.

Buisman LR, Luime JJ, Oppe M, Hazes JM, Rutten-van Mölken MP.

Value Health. 2015 Nov;18(7):A358-9. doi: 10.1016/j.jval.2015.09.684. Epub 2015 Oct 20. No abstract available.


Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease.

Pasma A, Schenk CV, Timman R, Busschbach JJ, van den Bemt BJ, Molenaar E, van der Laan WH, Schrauwen S, Van't Spijker A, Hazes JM.

Arthritis Res Ther. 2015 Oct 8;17:281. doi: 10.1186/s13075-015-0801-4.


Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.

Kuijper TM, Lamers-Karnebeek FB, Jacobs JW, Hazes JM, Luime JJ.

J Rheumatol. 2015 Nov;42(11):2012-22. doi: 10.3899/jrheum.141520. Epub 2015 Oct 1. Review.


Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low back pain; is one parameter present sufficient for primary care practice?

van Hoeven L, Koes BW, Hazes JM, Weel AE.

Ann Rheum Dis. 2015 Dec;74(12):e68. doi: 10.1136/annrheumdis-2015-208547. Epub 2015 Sep 28. No abstract available.


Nurses' views on patient self-management: a qualitative study.

Been-Dahmen JM, Dwarswaard J, Hazes JM, van Staa A, Ista E.

J Adv Nurs. 2015 Dec;71(12):2834-45. doi: 10.1111/jan.12767. Epub 2015 Sep 11.


Implementation of recommended non-pharmacotherapy in rheumatology practice: need for improvement.

van der Linden S, Boonen A, van Tubergen A, Vosse D, Dekker J, Dijkmans B, van der Horst-Bruinsma I, Kapinga T, van der Leeden M, van den Ende C, Hazes JM, Linssen A, Vliet Vlieland T.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1 Suppl 95):S15-7. Epub 2015 Aug 27. No abstract available.


Will the trilogue on the EU Data Protection Regulation recognise the importance of health research?

Coppen R, van Veen EB, Groenewegen PP, Hazes JM, de Jong JD, Kievit J, de Neeling JN, Reijneveld SA, Verheij RA, Vroom E.

Eur J Public Health. 2015 Oct;25(5):757-8. doi: 10.1093/eurpub/ckv149. Epub 2015 Aug 10. No abstract available.


External Validation of a Referral Rule for Axial Spondyloarthritis in Primary Care Patients with Chronic Low Back Pain.

van Hoeven L, Vergouwe Y, de Buck PD, Luime JJ, Hazes JM, Weel AE.

PLoS One. 2015 Jul 22;10(7):e0131963. doi: 10.1371/journal.pone.0131963. eCollection 2015.


Brief Report: Miscarriages in Female Rheumatoid Arthritis Patients: Associations With Serologic Findings, Disease Activity, and Antirheumatic Drug Treatment.

Brouwer J, Laven JS, Hazes JM, Dolhain RJ.

Arthritis Rheumatol. 2015 Jul;67(7):1738-43. doi: 10.1002/art.39137.


Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH.

van Nies JA, Alves C, Radix-Bloemen AL, Gaujoux-Viala C, Huizinga TW, Hazes JM, Brouwer E, Fautrel B, van der Helm-van Mil AH.

Arthritis Res Ther. 2015 Apr 23;17:108. doi: 10.1186/s13075-015-0616-3.


Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis.

Quax RA, Koper JW, Huisman AM, Weel A, Hazes JM, Lamberts SW, Feelders RA.

Rheumatol Int. 2015 Aug;35(8):1325-33. doi: 10.1007/s00296-015-3235-z. Epub 2015 Feb 28.


[Re-use of medical data for research. What do the Dutch think of the requirement for explicit consent?].

Coppen R, Groenewegen PP, Hazes JM, de Jong JD, Kievit J, de Neeling JN, Reijneveld SA, Verheij RA, Vroom E.

Ned Tijdschr Geneeskd. 2015;160:A9868. Dutch.


Facilitators and barriers to adherence in the initiation phase of Disease-modifying Antirheumatic Drug (DMARD) use in patients with arthritis who recently started their first DMARD treatment.

Pasma A, van 't Spijker A, Luime JJ, Walter MJ, Busschbach JJ, Hazes JM.

J Rheumatol. 2015 Mar;42(3):379-85. doi: 10.3899/jrheum.140693. Epub 2014 Dec 15.


Patient-reported joint count in juvenile idiopathic arthritis: the reliability of a manikin format.

Dijkstra ME, Anink J, van Pelt PA, Hazes JM, van Suijlekom-Smit LW.

J Rheumatol. 2015 Mar;42(3):527-33. doi: 10.3899/jrheum.140073. Epub 2014 Nov 29.


How to study determinants related to medication adherence in newly diagnosed polyarthritis patients for the development of a prediction instrument.

Pasma A, Hazes JM, Luime JJ, Busschbach JJ, van 't Spijker A.

Patient Prefer Adherence. 2014 Oct 20;8:1437-47. doi: 10.2147/PPA.S66922. eCollection 2014.

Supplemental Content

Loading ...
Support Center